Cargando…

Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma

Background: Recurrence in pleomorphic adenoma (PA) has been debated as a risk factor for malignant transformation (MT). In this study, we investigated whether recurrence is a risk factor for MT, by longitudinally analyzing cases with recurrent PA (RPA), and carcinomas from PA (CXPA) or RPA (CXRPA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sung Yong, Choi, Jaehyuck, Hwang, Inwoo, Cho, Junhun, Ko, Young-Hyeh, Jeong, Han-Sin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999507/
https://www.ncbi.nlm.nih.gov/pubmed/35407417
http://dx.doi.org/10.3390/jcm11071808
_version_ 1784685202426036224
author Choi, Sung Yong
Choi, Jaehyuck
Hwang, Inwoo
Cho, Junhun
Ko, Young-Hyeh
Jeong, Han-Sin
author_facet Choi, Sung Yong
Choi, Jaehyuck
Hwang, Inwoo
Cho, Junhun
Ko, Young-Hyeh
Jeong, Han-Sin
author_sort Choi, Sung Yong
collection PubMed
description Background: Recurrence in pleomorphic adenoma (PA) has been debated as a risk factor for malignant transformation (MT). In this study, we investigated whether recurrence is a risk factor for MT, by longitudinally analyzing cases with recurrent PA (RPA), and carcinomas from PA (CXPA) or RPA (CXRPA). Methods: The study population included 24 CXPA, 24 RPA, 6 CXRPA, and 386 PA cases (study period 2010–2018). Time and event data were collected from the medical documents to identify the time–event sequences. Results: The time interval to MT in CXRPA was significant longer than that of benign recurrence (median 342.0 vs. 109.5 months). In CXRPA, the recurrence intervals were not shorter than those in RPA according to recurrence frequency. Crudely, the MT rate was 5.9% among primary cases and 20.0% among recurrent cases. However, the time-adjusted MT rates increased up to 11.4% (incubation time > 60 months) and 20.0% (>120 months) in primary cases, which were not different from recurrent cases. Conclusion: In these longitudinal analyses, we did not find any clinical evidence that recurrence facilitates MT in the background of PA. Instead, a long incubation time seems to be a key factor for MT of underlying RPA.
format Online
Article
Text
id pubmed-8999507
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89995072022-04-12 Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma Choi, Sung Yong Choi, Jaehyuck Hwang, Inwoo Cho, Junhun Ko, Young-Hyeh Jeong, Han-Sin J Clin Med Article Background: Recurrence in pleomorphic adenoma (PA) has been debated as a risk factor for malignant transformation (MT). In this study, we investigated whether recurrence is a risk factor for MT, by longitudinally analyzing cases with recurrent PA (RPA), and carcinomas from PA (CXPA) or RPA (CXRPA). Methods: The study population included 24 CXPA, 24 RPA, 6 CXRPA, and 386 PA cases (study period 2010–2018). Time and event data were collected from the medical documents to identify the time–event sequences. Results: The time interval to MT in CXRPA was significant longer than that of benign recurrence (median 342.0 vs. 109.5 months). In CXRPA, the recurrence intervals were not shorter than those in RPA according to recurrence frequency. Crudely, the MT rate was 5.9% among primary cases and 20.0% among recurrent cases. However, the time-adjusted MT rates increased up to 11.4% (incubation time > 60 months) and 20.0% (>120 months) in primary cases, which were not different from recurrent cases. Conclusion: In these longitudinal analyses, we did not find any clinical evidence that recurrence facilitates MT in the background of PA. Instead, a long incubation time seems to be a key factor for MT of underlying RPA. MDPI 2022-03-25 /pmc/articles/PMC8999507/ /pubmed/35407417 http://dx.doi.org/10.3390/jcm11071808 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Choi, Sung Yong
Choi, Jaehyuck
Hwang, Inwoo
Cho, Junhun
Ko, Young-Hyeh
Jeong, Han-Sin
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
title Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
title_full Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
title_fullStr Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
title_full_unstemmed Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
title_short Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
title_sort comparative longitudinal analysis of malignant transformation in pleomorphic adenoma and recurrent pleomorphic adenoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999507/
https://www.ncbi.nlm.nih.gov/pubmed/35407417
http://dx.doi.org/10.3390/jcm11071808
work_keys_str_mv AT choisungyong comparativelongitudinalanalysisofmalignanttransformationinpleomorphicadenomaandrecurrentpleomorphicadenoma
AT choijaehyuck comparativelongitudinalanalysisofmalignanttransformationinpleomorphicadenomaandrecurrentpleomorphicadenoma
AT hwanginwoo comparativelongitudinalanalysisofmalignanttransformationinpleomorphicadenomaandrecurrentpleomorphicadenoma
AT chojunhun comparativelongitudinalanalysisofmalignanttransformationinpleomorphicadenomaandrecurrentpleomorphicadenoma
AT koyounghyeh comparativelongitudinalanalysisofmalignanttransformationinpleomorphicadenomaandrecurrentpleomorphicadenoma
AT jeonghansin comparativelongitudinalanalysisofmalignanttransformationinpleomorphicadenomaandrecurrentpleomorphicadenoma